Giugliano, D., De Nicola, L., Maiorino, M. I., & Esposito, K. (2025). Semaglutide cuts kidney risk in obesity. Journal of Endocrinological Investigation: Official Journal of Italian Society of Endocrinology (SIE), 48(2), 295-298. https://doi.org/10.1007/s40618-024-02494-0
Chicago Style (17th ed.) CitationGiugliano, Dario, Luca De Nicola, Maria Ida Maiorino, and Katherine Esposito. "Semaglutide Cuts Kidney Risk in Obesity." Journal of Endocrinological Investigation: Official Journal of Italian Society of Endocrinology (SIE) 48, no. 2 (2025): 295-298. https://doi.org/10.1007/s40618-024-02494-0.
MLA (9th ed.) CitationGiugliano, Dario, et al. "Semaglutide Cuts Kidney Risk in Obesity." Journal of Endocrinological Investigation: Official Journal of Italian Society of Endocrinology (SIE), vol. 48, no. 2, 2025, pp. 295-298, https://doi.org/10.1007/s40618-024-02494-0.